{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:46:51Z","timestamp":1790959611500,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bmcl.2024.129623","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T03:33:06Z","timestamp":1705635186000},"page":"129623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Inhibition of dengue viruses by N-methylcytisine thio derivatives through targeting viral envelope protein and NS2B-NS3 protease"],"prefix":"10.1016","volume":"99","author":[{"given":"Chen-Sheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8363-6244","authenticated-orcid":false,"given":"Chih-Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Hsiu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Tung","family":"Kiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Ying","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Yi","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena V.","family":"Koval'skaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4551-0226","authenticated-orcid":false,"given":"Dmitry O.","family":"Tsypyshev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna P.","family":"Tsypysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129623_b0005","unstructured":"WHO. (2021). Dengue and severe dengue. Retrieved fromhttps:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue."},{"key":"10.1016\/j.bmcl.2024.129623_b0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2024.129623_b0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/B978-0-12-819400-3.00016-8","article-title":"Dengue Virus","volume":"2020","author":"Murugesan","year":"2020","journal-title":"Emerging and Reemerging Viral Pathogens"},{"key":"10.1016\/j.bmcl.2024.129623_b0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mjafi.2014.09.011","article-title":"Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control","volume":"71","author":"Mustafa","year":"2015","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.bmcl.2024.129623_b0025","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","article-title":"The immune response against flaviviruses","volume":"19","author":"Slon Campos","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bmcl.2024.129623_b0030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/clinids\/19.3.500","article-title":"Antibody-dependent enhancement of infection and the pathogenesis of viral disease","volume":"19","author":"Morens","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2024.129623_b0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15252\/embr.201745302","article-title":"The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design","volume":"19","author":"Rey","year":"2018","journal-title":"EMBO Rep"},{"key":"10.1016\/j.bmcl.2024.129623_b0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2024.129623_b0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Perera","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.bmcl.2024.129623_b0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/v3020160","article-title":"Flavivirus cell entry and membrane fusion","volume":"3","author":"Smit","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2024.129623_b0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 \u00c5 resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2024.129623_b0060","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1038\/s41598-017-10901-1","article-title":"Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques","volume":"7","author":"George","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2024.129623_b0065","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1038\/nrmicro2459","article-title":"Evaluation of diagnostic tests: dengue","volume":"8","author":"Peeling","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmcl.2024.129623_b0070","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7150\/ijms.5037","article-title":"Inhibition of dengue virus entry into target cells using synthetic antiviral peptides","volume":"10","author":"Alhoot","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.bmcl.2024.129623_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104636","article-title":"A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses","volume":"172","author":"Yang","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2024.129623_b0080","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/aps.2015.56","article-title":"Policresulen, a novel NS2B\/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bmcl.2024.129623_b0085","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/cr400307e","article-title":"(-)-Cytisine and derivatives: synthesis, reactivity, and applications","volume":"114","author":"Rouden","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2024.129623_b0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(94)90200-3","article-title":"Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain","volume":"253","author":"Anderson","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2024.129623_b0095","doi-asserted-by":"crossref","unstructured":"Schmeller T, Wink M. Utilization of alkaloids in modern medicine. Alkaloids: Biochemistry, Ecology and Medicinal Applications. New York, 1998; chapter 18, 435-459.","DOI":"10.1007\/978-1-4757-2905-4_18"},{"key":"10.1016\/j.bmcl.2024.129623_b0100","first-page":"1","article-title":"Alkaloid-important therapeutic secondary metabolites of plant origin","volume":"2","author":"Kaur","year":"2015","journal-title":"J Crit Rev"},{"key":"10.1016\/j.bmcl.2024.129623_b0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ptr.949","article-title":"In vitro Inhibition of HHV-6 replication by sophocarpines","volume":"16","author":"Qavi","year":"2002","journal-title":"Phytother Res"},{"key":"10.1016\/j.bmcl.2024.129623_b0110","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1021\/acs.jnatprod.5b00325","article-title":"Antiviral Matrine-Type Alkaloids from the Rhizomes of Sophora tonkinensis","volume":"78","author":"Pan","year":"2015","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmcl.2024.129623_b0115","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.2174\/092986710793176375","article-title":"Design and development of anti-hepatitis B virus agents","volume":"17","author":"Kaushik","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2024.129623_b0120","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.bmcl.2017.03.025","article-title":"Evolution of matrinic ethanol derivatives as anti-HCV agents from matrine skeleton","volume":"27","author":"Li","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129623_b0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/acsmedchemlett.5b00339","article-title":"Aloperine and Its Derivatives as a New Class of HIV-1 Entry Inhibitors","volume":"7","author":"Dang","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129623_b0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/13894501113146660203","article-title":"The medicinal potential of natural products for the development of anti- influenza agents","volume":"15","author":"Sun","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bmcl.2024.129623_b0135","first-page":"1","article-title":"Alkaloids as the natural anti-influenza virus agents: a systematic review","volume":"37","author":"Moradi","year":"2017","journal-title":"Toxin Rev"},{"key":"10.1016\/j.bmcl.2024.129623_b0140","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/ml500236n","article-title":"Identification and synthesis of quinolizidines with anti-influenza a virus activity","volume":"5","author":"Dang","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129623_b0145","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/j.tet.2019.04.021","article-title":"Diels-Alder Adducts of 3-N-substituted Derivatives of (-)-Cytisine as Influenza A\/H1N1 Virus Inhibitors; Stereodifferentiation of antiviral Properties and Preliminary Assessment of Action Mechanism","volume":"75","author":"Tsypysheva","year":"2019","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2024.129623_b0150","first-page":"1","article-title":"Antiviral activity of amides and carboxamides of quinolizidine alkaloid (-)-cytisine against human influenza virus A (H1N1) and parainfluenza virus type 3","author":"Fedorova","year":"2019","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2024.129623_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128437","article-title":"Synthesis and antiviral evaluation of cytisine derivatives against dengue virus types 1 and 2","volume":"54","author":"Tsypysheva","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129623_b0160","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.3390\/biomedicines11102754","article-title":"The Antiviral Activity of Varenicline against Dengue Virus Replication during the Post-Entry Stage","volume":"11","author":"Lin","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bmcl.2024.129623_b0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/14786419.2019.1622106","article-title":"Variation of spacer type and topology of phenyl moiety in 2-pyridone core of 4-oxo-3-N-methylcytisine; effect of synthesized compounds on rat's behavior in conditioned passive avoidance reflex (CPAR) test","volume":"35","author":"Tsypysheva","year":"2021","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2024.129623_b0170","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1080\/14786419.2020.1868460","article-title":"Thionation of quinolizidine alkaloids and their derivatives via Lawesson's reagent","volume":"36","author":"Koval'skaya","year":"2022","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2024.129623_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126645","article-title":"Glycyrrhizic acid derivatives as Dengue virus inhibitors","volume":"29","author":"Baltina","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129623_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2019.197767","article-title":"Antiviral activity of Sambucus Formosana Nakai ethanol extract and related phenolic acid constituents against human coronavirus NL63","volume":"273","author":"Weng","year":"2019","journal-title":"Virus Res"},{"key":"10.1016\/j.bmcl.2024.129623_b0185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00894-017-3259-2","article-title":"Targeting domain-III hinging of dengue envelope (DENV-2) protein by MD simulations, docking and free energy calculations","volume":"23","author":"Dubey","year":"2017","journal-title":"J Mol Model"},{"key":"10.1016\/j.bmcl.2024.129623_b0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmcl.2024.129623_b0195","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2024.129623_b0200","doi-asserted-by":"crossref","first-page":"I6","DOI":"10.1021\/jm050540c","article-title":"Novel Procedure for Modeling Ligand\/Receptor Induced Fit Effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129623_b0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","article-title":"Use of an Induced Fit Receptor Structure in Virtual Screening","volume":"67","author":"Sherman","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2024.129623_b0210","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1128\/JVI.02044-09","article-title":"Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family","volume":"84","author":"Chandramouli","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.bmcl.2024.129623_b0215","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmcl.2024.129623_b0220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/prot.20035","article-title":"GEMDOCK: a generic evolutionary method for molecular docking","volume":"55","author":"Yang","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.bmcl.2024.129623_b0225","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1128\/JVI.02574-08","article-title":"Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion","volume":"83","author":"Nayak","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.bmcl.2024.129623_b0230","doi-asserted-by":"crossref","unstructured":"Norshidah H, Leow CH, Ezleen KE, et al.Assessing the potential of NS2B\/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach. Front Cell Infect Microbiol. 2023; 13:1061937.","DOI":"10.3389\/fcimb.2023.1061937"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:50:03Z","timestamp":1760773803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":46,"alternative-id":["S0960894X24000258"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129623","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of dengue viruses by N-methylcytisine thio derivatives through targeting viral envelope protein and NS2B-NS3 protease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129623"}}